You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 10,124,056


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,124,056
Title:Alkylated influenza vaccines
Abstract: The present invention provides, among other things, improved influenza vaccines based on hemagglutinins containing one or more alkylated cysteine residues. In particular, the present invention provides influenza vaccines containing hemagglutinins treated with an alkylating agent and methods of making the same. Inventive influenza vaccines provided by the present invention have a remarkable ability to retain potency as determined by Single Radial Immunodiffusion (SRID) assay upon storage.
Inventor(s): Milner; Brooke S. (Easton, PA), Haines; Jonathan (Effort, PA), Hauser; Steven L. (Easton, PA), Poli; Janet Beebe (Bethlehem, PA)
Assignee: Sanofi Pasteur Inc. (Swiftwater, PA)
Application Number:14/829,158
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,124,056

Introduction

Understanding the claims and patent landscape of a specific patent, such as United States Patent 10,124,056, involves a detailed analysis of several key aspects, including the patent's claims, the technological context, and the broader patent landscape. This article will delve into these areas to provide a comprehensive and critical analysis.

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention and what is protected by the patent. The number and complexity of claims have been increasing over the years, driven by technological innovation and legal precedents[2].

Importance of Claims

The business and legal value of a patent resides primarily in its claims. These claims must be carefully crafted to ensure they are patent-eligible and provide meaningful protection for the invention. The USPTO guidance updates, such as the 2024 update on AI patents, emphasize the need for claims to integrate abstract ideas into practical applications to be considered patent-eligible[3].

Claim Structure and Analysis

For a patent like 10,124,056, analyzing the claims involves understanding their hierarchy and relationship. Tools like the Patent Matrix software can help in automating the import, parsing, and compression of claims to facilitate a clearer understanding of the patent's scope[2].

Technological Context

The technological context in which a patent is filed is crucial for understanding its significance and potential impact.

AI and Technological Innovation

The 2024 USPTO guidance update on AI patents highlights the growing importance of AI in patent filings. AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution. This means that patents like 10,124,056, if related to AI, must demonstrate concrete technological improvements and practical applications to be considered patent-eligible[3].

Global Patenting Trends

Global patenting trends, as analyzed in reports such as the Science and Engineering Indicators 2024, show that patents are increasingly filed in various technology areas, with a focus on time, technology, and country. The classification of patents under WIPO’s International Patent Classification (IPC) helps in understanding the technological areas in which patents like 10,124,056 are categorized[1].

Patent Landscape Analysis

Patent Assertion Entities (PAEs)

The patent landscape is also influenced by the activities of Patent Assertion Entities (PAEs). PAEs, such as Portfolio PAEs and Litigation PAEs, play a significant role in asserting patents, often in the ICT and software sectors. Understanding the business models of these entities can provide insights into how patents like 10,124,056 might be asserted or litigated[4].

International Collaborations

International collaborations, such as the US-JP Collaborative Search Pilot Program, facilitate the examination and granting of patents across different jurisdictions. This can impact the global reach and enforcement of patents like 10,124,056[5].

Country and Inventor Analysis

The country and inventor analysis is another critical aspect of patent landscape analysis.

Priority Country and Inventor Locations

The country assigned to a patent is often based on the priority country, which is the country of the earliest priority document in the patent family. For patents like 10,124,056, the country and inventor locations can be determined using fractional counts of inventors listed on the first granted patent or other patent documents in the family[1].

Time Element and Trends

The time element in patent analysis involves tracking the publication year of patent applications and the issue date of granted patents.

Trends Over Time

Analyzing trends over time helps in understanding the evolution of technological areas and the impact of patents like 10,124,056. This involves looking at the number of patent applications and grants over the years, as well as the technological categories in which they are classified[1].

Practical Applications and Real-World Benefits

To ensure patent eligibility, claims must demonstrate practical applications and real-world benefits.

Case Law and Examples

The 2024 USPTO guidance update provides examples of patent-eligible and ineligible claims, emphasizing the need for claims to integrate abstract ideas into practical applications. For instance, a claim that specifies the use of separated audio components in a speech recognition system to enhance accuracy is considered patent-eligible because it provides a tangible outcome[3].

Challenges and Opportunities

Increasing Complexity

The increasing number and complexity of patent claims pose significant challenges for patent holders and examiners. Automated systems and tools are essential for managing this complexity and ensuring that claims are properly analyzed and understood[2].

Legal and Regulatory Environment

The legal and regulatory environment, including updates to USPTO guidance and international collaborations, presents both challenges and opportunities. Staying abreast of these changes is crucial for navigating the patent landscape effectively.

Key Takeaways

  • Claims Analysis: The claims of a patent define its scope and must be carefully analyzed to ensure patent eligibility and meaningful protection.
  • Technological Context: The technological context, including AI and global patenting trends, is essential for understanding the significance and potential impact of a patent.
  • PAEs and Litigation: PAEs play a significant role in the patent landscape, and understanding their business models can provide insights into patent assertion and litigation.
  • Country and Inventor Analysis: The country and inventor locations are critical for determining the origin and ownership of a patent.
  • Practical Applications: Claims must demonstrate practical applications and real-world benefits to be considered patent-eligible.

FAQs

Q: What is the significance of the claims in a patent? A: The claims in a patent define the scope of the invention and are crucial for determining what is protected by the patent.

Q: How does the 2024 USPTO guidance update impact AI patents? A: The update clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of abstract ideas into practical applications.

Q: What role do Patent Assertion Entities (PAEs) play in the patent landscape? A: PAEs assert patents, often in the ICT and software sectors, and can significantly influence the patent landscape through their litigation and licensing activities.

Q: How is the country assigned to a patent determined? A: The country assigned to a patent is typically based on the priority country, which is the country of the earliest priority document in the patent family.

Q: Why is it important to analyze the time element in patent trends? A: Analyzing the time element helps in understanding the evolution of technological areas and the impact of patents over time.

Sources

  1. National Science Foundation. Invention, Knowledge Transfer, and Innovation. Science and Engineering Indicators 2024: Technical Documentation.
  2. Google Patents. US20110138338A1 - Patent Claims Analysis System and Method.
  3. Mintz. Understanding the 2024 USPTO Guidance Update on AI Patent.
  4. Federal Trade Commission. Patent Assertion Entity Activity: An FTC Study.
  5. Japan Patent Office. US-JP Collaborative Search Pilot Program.

More… ↓

⤷  Subscribe

Details for Patent 10,124,056

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Seqirus Vaccines Limited FLUVIRIN influenza virus vaccine Injection 103837 November 03, 1998 ⤷  Subscribe 2034-08-18
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 December 09, 1999 ⤷  Subscribe 2034-08-18
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 December 23, 2009 ⤷  Subscribe 2034-08-18
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 May 09, 2011 ⤷  Subscribe 2034-08-18
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.